18F-FDG PET and CT/MRI in oral cavity squamous cell carcinoma: a prospective study of 124 patients with histologic correlation.

UNLABELLED Accurate evaluation of primary tumors and cervical lymph node status of squamous cell carcinoma (SCC) of the oral cavity is important to treatment planning and prognosis prediction. In this prospective study, we evaluated the use of 18F-FDG PET, CT/MRI, and their visual correlation for the identification of primary tumors and cervical nodal metastases of SCC of the oral cavity with histologic correlation. METHODS One hundred twenty-four patients with pathologically proven diagnoses of oral cavity SCC underwent 18F-FDG PET and CT/MRI within 2 wk before surgery. We interpreted 18F-FDG PET, CT/MRI, and visually correlated 18F-FDG PET and CT/MRI separately to assess the primary tumors and their regional lymph node status. We recorded lymph node metastases according to the neck level system of imaging-based nodal classification. Histopathologic analysis was used as the gold standard for assessment of the primary tumors and lymph node involvement. We analyzed differences in sensitivity and specificity among the imaging modalities using the McNemar test. The receiver-operating-characteristic (ROC) curve and calculation of the area under the curve were used to evaluate their discriminative power. RESULTS The accuracy of 18F-FDG PET, CT/MRI, and their visual correlation for the identification of primary tumors was 98.4%, 87.1%, and 99.2%, respectively. The sensitivity of 18F-FDG PET for the identification of nodal metastases on a level-by-level basis was 22.1% higher than that of CT/MRI (74.7% vs. 52.6%, P < 0.001), whereas the specificity of 18F-FDG PET was 1.5% lower than that of CT/MRI (93.0% vs. 94.5%, P = 0.345). The sensitivity and specificity of the visual correlation of 18F-FDG PET and CT/MRI were 3.2% and 1.5% higher than those of 18F-FDG PET alone (77.9% vs. 74.7%, P = 0.25; 94.5% vs. 93.0%, P = 0.18, respectively). The area under the curve obtained from the ROC curve showed that 18F-FDG PET was significantly superior to CT/MRI for total nodal detection (0.896 vs. 0.801, P = 0.002), whereas the visual correlation of 18F-FDG PET and CT/MRI was modestly superior to 18F-FDG PET alone (0.913 vs. 0.896, P = 0.28). CONCLUSION 18F-FDG PET is superior to CT/MRI in the detection of cervical status of oral cavity SCC. The sensitivity of 18F-FDG PET for the detection of cervical nodal metastasis on a level-by-level basis was significantly higher than that of CT/MRI, whereas their specificities appeared to be similar. Visual correlation of 18F-FDG PET and CT/MRI showed a trend of increased diagnostic accuracy over 18F-FDG PET alone but without a statistically significant difference, and its sensitivity was still not high enough to replace pathologic lymph node staging based on neck dissection.

[1]  Mithat Gonen,et al.  Head and neck cancer: clinical usefulness and accuracy of PET/CT image fusion. , 2004, Radiology.

[2]  B. Beuthien-Baumann,et al.  FDG-PET in the pretherapeutic evaluation of primary squamous cell carcinoma of the oral cavity and the involvement of cervical lymph nodes. , 2002, Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging.

[3]  J. Woolgar,et al.  Pathological findings in clinically false-negative and false-positive neck dissections for oral carcinoma. , 1994, Annals of the Royal College of Surgeons of England.

[4]  J L Roodenburg,et al.  Detection of lymph node metastases of squamous-cell cancer of the head and neck with FDG-PET and MRI. , 1995, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[5]  Chan Km Betel nut chewing and mouth cancer in Taiwan. 2. Observation of the oral mucosa in the betel nut chewer. , 1966 .

[6]  Scott T. Grafton,et al.  PET and [18F]-FDG in oncology: a clinical update. , 1996, Nuclear medicine and biology.

[7]  H. Curtin,et al.  Imaging-based nodal classification for evaluation of neck metastatic adenopathy. , 2000, AJR. American journal of roentgenology.

[8]  K. Geisinger,et al.  A comparative diagnostic study of head and neck nodal metastases using positron emission tomography , 1995, The Laryngoscope.

[9]  R. Lufkin,et al.  Evaluation of cervical lymph node metastases in squamous cell carcinoma of the head and neck , 1995, The Laryngoscope.

[10]  R. Lufkin,et al.  Use of positron emission tomography with fluorodeoxyglucose in patients with extracranial head and neck cancers. , 1994, Cancer.

[11]  P. V. van Rijk,et al.  Preoperative evaluation of patients with primary head and neck cancer using dual-head 18fluorodeoxyglucose positron emission tomography. , 2000, Annals of surgery.

[12]  R. Baum,et al.  Staging of the neck in patients with oral cavity squamous cell carcinomas: a prospective comparison of PET, ultrasound, CT and MRI. , 2000, Journal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery.

[13]  M Schwaiger,et al.  Comparison of fluorine-18-fluorodeoxyglucose PET, MRI and endoscopy for staging head and neck squamous-cell carcinomas. , 1995, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[14]  C. Metz ROC Methodology in Radiologic Imaging , 1986, Investigative radiology.

[15]  R. Felix,et al.  [Magnetic resonance tomography and computerized tomography in tumor staging of mouth and oropharyngeal cancer]. , 1993, HNO.

[16]  W N Hanafee,et al.  Extracranial head and neck: PET imaging with 2-[F-18]fluoro-2-deoxy-D-glucose and MR imaging correlation. , 1993, Radiology.

[17]  K. M. Chang Betel nut chewing and mouth cancer in Taiwan. 2. Observation of the oral mucosa in the betel nut chewer. , 1966, Taiwan yi xue hui za zhi. Journal of the Formosan Medical Association.

[18]  H. Baddeley,et al.  A prospective study of PET-FDG imaging for the assessment of head and neck squamous cell carcinoma. , 1997, Clinical otolaryngology and allied sciences.

[19]  F. Maes,et al.  FDG-PET scan in potentially operable non-small cell lung cancer: do anatometabolic PET-CT fusion images improve the localisation of regional lymph node metastases? , 1998, European Journal of Nuclear Medicine.

[20]  R. Hayden,et al.  Neck neoplasms: MR imaging. Part I. Initial evaluation. , 1986, Radiology.

[21]  G. Snow,et al.  Management of cervical lymph nodes in patients with head and neck cancer , 2004, European Archives of Oto-Rhino-Laryngology.

[22]  J. Langdon,et al.  Management of oral cancer. , 1995, Annals of the Royal College of Surgeons of England.

[23]  W. Steiner [Early detection of cancer in the upper aerodigestive tract. Part I]. , 1993, HNO.

[24]  Diego R. Martín,et al.  Comparison of MR and PET imaging for the evaluation of liver metastases , 2003, Journal of magnetic resonance imaging : JMRI.

[25]  G. V. von Schulthess,et al.  Staging of non-small-cell lung cancer with integrated positron-emission tomography and computed tomography. , 2003, The New England journal of medicine.

[26]  M. Schwaiger,et al.  Lymph node detection of head and neck squamous cell carcinomas by positron emission tomography with fluorodeoxyglucose F 18 in a routine clinical setting. , 1999, Archives of otolaryngology--head & neck surgery.

[27]  Yu-Chen Chang,et al.  Nodal metastases of nasopharyngeal carcinoma: patterns of disease on MRI and FDG PET , 2004, European Journal of Nuclear Medicine and Molecular Imaging.

[28]  E Abemayor,et al.  Positron emission tomography: A new, precise imaging modality for detection of primary head and neck tumors and assessment of cervical adenopathy , 1992, The Laryngoscope.

[29]  G. Hör,et al.  Prospective comparison of 18F-FDG PET with conventional imaging modalities (CT, MRI, US) in lymph node staging of head and neck cancer , 1998, European Journal of Nuclear Medicine.

[30]  S. Berlangieri,et al.  Evaluation of 18F-Fluorodeoxyglucose Positron Emission Tomography and Computed Tomography With Histopathologic Correlation in the Initial Staging of Head and Neck Cancer , 2002 .

[31]  B. Nowak,et al.  Diagnostic Evaluation of Malignant Head and Neck Cancer by F-18-FDG PET Compared to CT/MRI , 1999, Nuklearmedizin.

[32]  N Cascinelli,et al.  Which kinds of lymph node metastases can FDG PET detect? A clinical study in melanoma. , 2000, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[33]  D. Slosman,et al.  The role of FDG-PET in the preoperative assessment of N-staging in head and neck cancer. , 1996, Acta oto-laryngologica.